企业资质

Guangzhou Quanao Chemical Co.,Ltd

普通会员11
|
企业等级:普通会员
经营模式:
所在地区:湖北 武汉
联系卖家:
手机号码:
企业地址:
本企业已通过工商资料核验!
企业概况

GuangzhouQuanaoChemicalCo.,Ltd,aleadingsupplieroffinechemicalinChina,islocatedinShenzhen.TheuniquegeographicalconditionsofShenzhenarefavorablefortrans......

Safety Dutasteride

产品编号:6192194                    更新时间:2015-03-31
价格: 来电议定

Guangzhou Quanao Chemical Co.,Ltd

联系人名片:

联系时务必告知是在"产品网"看到的

产品详情

Safety Dutasteride / ***odart  Powder For Women / Men Hair Loss Treatment CAS 164656-23-9
Other name:DUTASTERIDE; Duagen; ***odart
CAS No: 164656-23-9
MF: C27H30F6N2O2
MW: 528.53
Purity: 99%
Appearance: White powder.
USES: Medicine material. The treatment of prostate hyperplasia.
skype:tracy665       email tracy at ycphar dot com

Description:
Dutasteride (trademark name ***odart) is a dual 5-α reductase inhibitor that inhibits conversion of *** to dihydro*** (DHT). Used for benign prostatic hyperplasia; however, it increases the risk of erectile dysfunction and decreased sexual desire.
Dutasteride useful for the symptoms of benign prostatic hyperplasia (BPH); colloquially known as an "enlarged prostate".
In those who are being regularly screened 5-alpha-reductase inhibitor (finasteride and dutasteride) reduce the overall risk of being diagnosed with prostate cancer however there is insufficient data to determine if they h***e an effect on the risk of death and may increase the chance of more serious cases.
This class of medicati*** increases rates of erectile dysfunction (with between 5% and 9% developing problems after starting their use). This is linked to lower quality of life and can cause stress in relati***hips. There is also an association with lowered sexual desire. It has been reported that these adverse sexual side effects may persist even after discontinuation of the drug.
The FDA has added a warning to dutasteride about an increased risk of high-grade prostate cancer. While the potential for positive, negative or neutral changes to the potential risk of developing prostate cancer with dutasteride has not been established, evidence has suggested it may temporarily reduce the growth and prevalence of benign prostate tumors, but could also mask the early detection of prostate cancer. The primary area for concern is for patients who may develop prostate cancer whilst taking dutasteride for benign prostatic hyperplasia, which in turn could delay diagnosis and early treatment of the prostate cancer, thereby potentially increasing the risk of these patients developing high-grade prostate cancer.

COA:
Product name Dutasteride 
Appearance White crystalline powder 
Assay(*) 98~101.0% 99.4% 
Identification By UV, To match with working standard Complies 
Related Substances Not more than the reference solution (0.05%) Complies 
He***y metals ¡Ü10ppm 9ppm 
Loss on drying <0.5% 0.2% 
Resiue on ignition ¡Ü0.1% 0.05% 
Melting 242¡ãC~250¡ãC 245¡ãC 
 

 

Guangzhou Quanao Chemical Co.,Ltd电话:传真:联系人:

地址:主营产品:Pharmaceutical intermediates

Copyright © 2025 版权所有: 产品网店铺主体:Guangzhou Quanao Chemical Co.,Ltd

免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责。产品网对此不承担任何保证责任。